Literature DB >> 2375910

Two novel polyadenylation mutations leading to beta(+)-thalassemia.

L Jankovic1, G D Efremov, G Petkov, C Kattamis, E George, K G Yang, T A Stoming, T H Huisman.   

Abstract

In an ongoing effort to identify point mutations causing beta-thalassaemia, we have found two previously unreported mutations which are located in the Poly A site of the beta-globin gene. The screening programme used amplified DNA and dot-blot hybridization with several 32P-labelled oligonucleotide probes. DNA samples which remained unidentified by this methodology were subjected to sequencing with 32P-labelled primers and modified T7 DNA polymerase. The newly discovered mutations were confirmed by the dot-blot hybridization technique. One type concerned an AATAAA----AATGAA mutation in the polyadenylation site and was found in one family from Yugoslavia (including one patient with the C----T mutation at codon 29 in trans), one from Bulgaria (the patient had the G----A mutation at IVS-I-110 in trans), and one from Greece (this patient had the C----G mutation at IVS-II-745 in trans). Haematological data for three simple heterozygotes suggested a rather mild beta(+)-thalassemia. The second type involved an AATAAA----AATAGA mutation and was found in one family from Malaysia. The propositus had the beta E mutation on the other chromosome, was originally diagnosed as mild Hb E-beta(+)-thalassaemia, and had Hb A and Hb E percentages which were nearly the same.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2375910     DOI: 10.1111/j.1365-2141.1990.tb02627.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

1.  Patterns of variant polyadenylation signal usage in human genes.

Authors:  E Beaudoing; S Freier; J R Wyatt; J M Claverie; D Gautheret
Journal:  Genome Res       Date:  2000-07       Impact factor: 9.043

2.  Beta-thalassaemia: molecular pathogenesis and clinical variability.

Authors:  A E Kulozik
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

Review 3.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-04-28       Impact factor: 4.132

4.  The human GIMAP5 gene has a common polyadenylation polymorphism increasing risk to systemic lupus erythematosus.

Authors:  Anna Hellquist; Marco Zucchelli; Katja Kivinen; Ulpu Saarialho-Kere; Sari Koskenmies; Elisabeth Widen; Heikki Julkunen; Andrew Wong; Marja-Liisa Karjalainen-Lindsberg; Tiina Skoog; Johanna Vendelin; Deborah S Cunninghame-Graham; Timothy J Vyse; Juha Kere; Cecilia M Lindgren
Journal:  J Med Genet       Date:  2007-01-12       Impact factor: 6.318

Review 5.  3' end mRNA processing: molecular mechanisms and implications for health and disease.

Authors:  Sven Danckwardt; Matthias W Hentze; Andreas E Kulozik
Journal:  EMBO J       Date:  2008-02-06       Impact factor: 11.598

Review 6.  Control of human beta-globin mRNA stability and its impact on beta-thalassemia phenotype.

Authors:  Isabel Peixeiro; Ana Luísa Silva; Luísa Romão
Journal:  Haematologica       Date:  2011-02-28       Impact factor: 9.941

7.  Scanning of beta-globin gene for identification of beta-thalassemia mutation in Romanian population.

Authors:  R Talmaci; J Traeger-Synodinos; E Kanavakis; D Coriu; D Colita; L Gavrila
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

8.  Disease-associated mutations that alter the RNA structural ensemble.

Authors:  Matthew Halvorsen; Joshua S Martin; Sam Broadaway; Alain Laederach
Journal:  PLoS Genet       Date:  2010-08-19       Impact factor: 5.917

9.  Silent carrier beta-thalassaemia due to a severe beta-globin mutation interacting with other genetic elements.

Authors:  D Rund; D Filon; A Oppenheim; A Abramov
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

10.  Homozygous beta+ thalassaemia owing to a mutation in the cleavage-polyadenylation sequence of the human beta globin gene.

Authors:  M Losekoot; R Fodde; C L Harteveld; H van Heeren; P C Giordano; L N Went; L F Bernini
Journal:  J Med Genet       Date:  1991-04       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.